Page last updated: 2024-09-03

desloratadine and Hives

desloratadine has been researched along with Hives in 75 studies

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's42 (56.00)29.6817
2010's32 (42.67)24.3611
2020's1 (1.33)2.80

Authors

AuthorsStudies
Chen, W; Chen, X; Li, J; Liu, Z; Peng, C; Su, J; Zhang, W; Zhu, W1
Pang, GX; Qiu, XJ; Shi, YS; Wang, QM1
Ben Chibani, J; Helal, AN; Kassab, A; Leban, N; Maouia, A; Youssef, M1
Yang, X; Zheng, D1
Donnarumma, M; Gallo, R; Napolitano, M; Patruno, C1
Chaowattanapanit, S; Choonhakarn, C; Julanon, N1
Chen, X; He, Y; Li, Q; Luo, Y; Yan, J; Yan, S1
Wang, J; Yan, X; Zhao, Y1
Meijer, JM; van Dalen, T; van der Wal, B1
Enk, CD; Hodak, E; Lapidoth, M; Levi, A; Mazor, S; Snast, I; Uvaidov, V1
Authried, G; Bracher, L; Bygum, A1
Bayramgürler, D; Bilen, N; Bulca, S; Kıran, R; Odyakmaz Demirsoy, E; Sikar Aktürk, A; Yavuz, M1
Arribas Granados, MP; Francés, L; Leiva-Salinas, M; Marin-Cabanas, I; Silvestre, JF1
Bennett, C; Carter, B; Cohen, SN; Sharma, M1
Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W1
Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zeng, W; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W1
Enk, CD; Levi, A1
Barkai, L; Izquierdo, I; Maurer, M; Mezei, G; Mitha, E; Potter, P; Santamaría, E1
Authried, G; Bracher, L; Eker, E; Svendsen, MT1
Bessis, D; Raison-Peyron, N; Reymann, V1
Bin, L; Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Leung, DY; Li, J; Liu, Z; Peng, C; Su, J; Yan, S; Yi, M; Zeng, W; Zhang, J; Zhang, W; Zhu, W1
Finlay, AY; Guillet, G; Hauptmann, P; Jian, AM; Kapp, A; Maurer, M; Potter, PC1
Auquier, P; Dreyfus, I; Grob, JJ; Ortonne, JP3
Degener, F; Martus, P; Maurer, M; Siebenhaar, F; Zuberbier, T1
Augustin, M; Ehrle, S1
dos Santos, RV; Lima, HC; Magerl, M; Mlynek, A1
Baskan, EB; Budak, F; Erturk, E; Gul, OO; Hacioglu, S; Imamoglu, S; Kiyici, S1
Bachert, C; Maurer, M1
Church, DS; Church, MK; Dimitrov, V; Kraeva, S; Kralimarkova, T; Lazarova, C; Popov, TA; Popova, D; Staevska, M1
Bérard, F; Boulinguez, S1
Chu, CY; Hong, JB; Hu, FC; Lee, HC1
Sackesen, C; Sahiner, UM; Tuncer, A; Yavuz, ST1
Bobadilla-González, P; Cámara-Hijón, C; García-Menaya, JM; Pérez-Rangel, I; Sánchez-Vega, S1
Chu, CY; Hong, JB; Lee, HC1
Church, MK; Magerl, M; Martus, P; Maurer, M; Pisarevskaja, D; Staubach, P1
Carter, NJ1
Church, MK; Maurer, M1
Ardelean, E; Martus, P; Maurer, M; Scholz, E; Weller, K; Zuberbier, T1
Bachert, C1
Monroe, EW1
Kockler, DR; Limon, L1
Sabbah, A1
Bernstein, D; Finn, A; Guerrero, R; Monroe, E; Patel, P; Ratner, P1
Frossard, N; Melac, M; Pauli, G; Purohit, A2
Juhlin, L1
Colanardi, MC; Ferrannini, A; Nettis, E; Paradiso, MT1
Di Lorenzo, G; Ditta, V; Esposito Pellitteri, M; Lo Bianco, C; Mansueto, P; Martinelli, N; Pacor, ML; Rini, GB1
Bloom, M; Herron, J; Staudinger, H1
Elbirt, D; Rottem, M; Sthoeger, Z1
Canonica, GW; Passalacqua, G1
DuBuske, LM1
Baltes, E; Benedetti, MS; Chatelain, P; Gillard, M1
Berger, WE1
Gupta, S; Kantesaria, B; Khalilieh, S; Kim, K; Lorber, R; Lutsky, B; Manitpisitkul, P; Prenner, B; Wang, Z1
Boonen, H; De Swerdt, A; Decroix, J; Henrijean, A; Lachapelle, JM; Lecuyer, M; Roquet-Gravy, PP; Speelman, G; Suys, E; Vastesaeger, N1
Amoruso, A; Cassano, N; D'Argento, V; Filieri, M; Filotico, R; Raho, G; Vena, GA1
Bachvarova, A; Bocsan, C; Church, MK; Dimitrov, V; Dumitrascu, D; Popov, TA1
Colanardi, MC; Ferrannini, A; Nettis, E; Soccio, AL; Vacca, A1
Kruszewski, J; Kruszewski, R; Kłos, K; Sułek, K1
Kruszewski, J; Kłos, K; Sułek, K1
DuBuske, L1
Frossard, N; Pauli, G; Purohit, A; Strolin-Benedetti, M1
Abdalla, AN; Khalaf, AT; Liu, XM; Sheng, WX; Tan, JQ1
Engin, B; Ozdemir, M1
Devillier, P; Faisy, C; Roche, N1
Affrime, MB; Banfield, C; Herron, JM; Lorber, R; Padhi, D; Salmun, LM1
Gauger, A; Hein, R; Ring, J1
Bronsky, E; Gauger, A; Hein, R; Miller, B; Ring, J1
Geha, RS; Meltzer, EO1
Jarvis, B; McClellan, K1

Reviews

17 review(s) available for desloratadine and Hives

ArticleYear
[Meta-analysis of efficacy and safety of Tripterygium Glycosides Tablets combined with desloratadine in treatment of chronic urticarial].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2019, Volume: 44, Issue:16

    Topics: Drug Therapy, Combination; Drugs, Chinese Herbal; Glycosides; Humans; Loratadine; Quality of Life; Randomized Controlled Trials as Topic; Tablets; Tripterygium; Urticaria

2019
H1-antihistamines for chronic spontaneous urticaria.
    The Cochrane database of systematic reviews, 2014, Nov-14, Issue:11

    Topics: Cetirizine; Cyproheptadine; Histamine H1 Antagonists; Humans; Hydroxyzine; Loratadine; Randomized Controlled Trials as Topic; Urticaria

2014
Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
    Clinical drug investigation, 2010, Volume: 30, Issue:2

    Topics: Activities of Daily Living; Adult; Anti-Allergic Agents; Chronic Disease; Female; Germany; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Nasal Obstruction; Pregnancy; Product Surveillance, Postmarketing; Pruritus; Rhinitis, Allergic, Seasonal; Sleep; Sneezing; Structure-Activity Relationship; Treatment Outcome; Urticaria

2010
[Diagnostic and physiopathological innovations related to chronic urticaria].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:5 Suppl 1

    Topics: Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoimmune Diseases; Blood Coagulation; Chronic Disease; Drug Eruptions; Female; Histamine H1 Antagonists, Non-Sedating; Histamine Release; Humans; Iodide Peroxidase; Loratadine; Mast Cells; Middle Aged; Omalizumab; Penicillins; Urticaria

2010
Bilastine: in allergic rhinitis and urticaria.
    Drugs, 2012, Jun-18, Volume: 72, Issue:9

    Topics: Area Under Curve; Benzimidazoles; Cetirizine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Urticaria

2012
H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2012, Volume: 42, Issue:10

    Topics: Anti-Allergic Agents; Cetirizine; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Predictive Value of Tests; Skin Tests; Terfenadine; Urticaria

2012
Therapeutic points of intervention and clinical implications: role of desloratadine.
    Allergy, 2002, Volume: 57 Suppl 75

    Topics: Asthma; Clinical Trials as Topic; Drug Administration Schedule; Histamine H1 Antagonists; Humans; Loratadine; Rhinitis, Allergic, Perennial; Urticaria

2002
Desloratidine for the treatment of chronic urticaria.
    Skin therapy letter, 2002, Volume: 7, Issue:8

    Topics: Chronic Disease; Histamine H1 Antagonists; Humans; Loratadine; Urticaria

2002
Desloratadine: a nonsedating antihistamine.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:2

    Topics: Adult; Area Under Curve; Child; Female; Half-Life; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Seasonal; Urticaria

2003
[The place of new antihistamines in allergy management. Apropos of desloratadine].
    Allergie et immunologie, 2002, Volume: 34, Issue:10

    Topics: Anti-Allergic Agents; Double-Blind Method; Half-Life; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Inflammation Mediators; Intercellular Adhesion Molecule-1; Liver; Loratadine; Meta-Analysis as Topic; Multicenter Studies as Topic; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Recombinant Proteins; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Safety; Treatment Outcome; Urticaria

2002
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
    Clinical therapeutics, 2005, Volume: 27, Issue:7

    Topics: Cetirizine; Histamine Antagonists; Humans; Loratadine; Nose; Piperazines; Quality of Life; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Skin; Urticaria

2005
Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14

    Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; Asthma; Child; Child, Preschool; Chronic Disease; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Loratadine; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2005
The safety and efficacy of desloratadine for the management of allergic disease.
    Drug safety, 2005, Volume: 28, Issue:12

    Topics: Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2005
Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
    Expert opinion on drug safety, 2006, Volume: 5, Issue:2

    Topics: Administration, Oral; Age Factors; Dose-Response Relationship, Drug; Electrocardiography; Histamine H1 Antagonists, Non-Sedating; Loratadine; Rhinitis, Allergic, Seasonal; Urticaria

2006
Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    American journal of clinical dermatology, 2007, Volume: 8, Issue:5

    Topics: Acetates; Adolescent; Adult; Child; Chronic Disease; Cyclopropanes; Drug Therapy, Combination; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Leukotriene Antagonists; Loratadine; Quality of Life; Quinolines; Sulfides; Urticaria

2007
Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
    Clinical pharmacokinetics, 2008, Volume: 47, Issue:4

    Topics: Cetirizine; Drug Interactions; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Terfenadine; Urticaria

2008
Desloratadine in the treatment of chronic idiopathic urticaria.
    Allergy, 2001, Volume: 56 Suppl 65

    Topics: Cholinergic Antagonists; Chronic Disease; Cytokines; Histamine H1 Antagonists; Humans; Loratadine; Severity of Illness Index; Time Factors; Treatment Outcome; Urticaria

2001

Trials

37 trial(s) available for desloratadine and Hives

ArticleYear
Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
    The pharmacogenomics journal, 2020, Volume: 20, Issue:1

    Topics: Adult; China; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Histamine H1; Severity of Illness Index; Sleepiness; Treatment Outcome; Urticaria

2020
CRP relevance in clinical assessment of chronic spontaneous urticaria Tunisian patients.
    Cutaneous and ocular toxicology, 2017, Volume: 36, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Antioxidants; C-Reactive Protein; Catalase; Chronic Disease; Female; Glutathione Peroxidase; Glutathione Transferase; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Severity of Illness Index; Superoxide Dismutase; Tunisia; Urticaria; Young Adult

2017
Clinical observation on the therapeutic effect of desloratadine citrate disodium in the treatment of chronic urticaria and changes in IL4, IL18, IL23 and IL-33 levels before and after treatment.
    Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:3(Special)

    Topics: Adolescent; Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Interleukin-18; Interleukin-23; Interleukin-33; Interleukin-4; Loratadine; Male; Middle Aged; Urticaria; Young Adult

2017
Effects of Desloratadine Citrate Disodium on Serum Immune Function Indices, Inflammatory Factors and Chemokines in Patients with Chronic Urticaria.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:3

    Topics: Administration, Oral; Adult; Biomarkers; Chemokine CCL5; Chemokines; China; Cholinergic Antagonists; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukins; Loratadine; Male; Middle Aged; Reference Values; Treatment Outcome; Urticaria

2019
Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers.
    The Journal of dermatological treatment, 2013, Volume: 24, Issue:6

    Topics: Administration, Oral; Adult; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Healthy Volunteers; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Time Factors; Urticaria; Young Adult

2013
Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
    Archives of dermatological research, 2015, Volume: 307, Issue:2

    Topics: Adult; Asian People; Benzimidazoles; China; Female; Genotyping Techniques; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Loratadine; Male; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Receptors, IgE; Terfenadine; Urticaria; Young Adult

2015
Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2016, Volume: 27, Issue:1

    Topics: Age Factors; Child; Child, Preschool; Chronic Disease; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hungary; Loratadine; Male; Quality of Life; Remission Induction; South Africa; Time Factors; Treatment Outcome; Urticaria

2016
Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Allergy, 2009, Volume: 64, Issue:4

    Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pruritus; Quality of Life; Severity of Illness Index; Urticaria

2009
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life.
    Allergy, 2009, Volume: 64, Issue:4

    Topics: Adult; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Urticaria

2009
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study.
    The Journal of allergy and clinical immunology, 2009, Volume: 123, Issue:3

    Topics: Adolescent; Adult; Aged; Cold Temperature; Cross-Over Studies; Double-Blind Method; Female; Histamine Antagonists; Humans; Loratadine; Male; Middle Aged; Prospective Studies; Urticaria; Young Adult

2009
Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2009, Volume: 102, Issue:6

    Topics: Adult; Allergens; Animals; Dermatophagoides pteronyssinus; Dibenzazepines; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Hydroxyzine; Imidazoles; Loratadine; Male; Middle Aged; Rhinitis, Allergic, Perennial; Skin Tests; Terfenadine; Treatment Outcome; Urticaria

2009
Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:6

    Topics: Adolescent; Adult; Autoimmune Diseases; Chi-Square Distribution; Chronic Disease; Drug Combinations; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Hypothyroidism; Interferon-gamma; Interleukin-10; Loratadine; Male; Middle Aged; Prospective Studies; Thyroxine; Treatment Outcome; Tumor Necrosis Factor-alpha; Urticaria; Young Adult

2010
The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
    The Journal of allergy and clinical immunology, 2010, Volume: 125, Issue:3

    Topics: Adult; Aged; Cetirizine; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Quality of Life; Urticaria; Young Adult

2010
A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria.
    Journal of the American Academy of Dermatology, 2010, Volume: 63, Issue:5

    Topics: Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Pilot Projects; Sleep Stages; Urticaria

2010
Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation.
    The British journal of dermatology, 2012, Volume: 166, Issue:5

    Topics: Adult; Aged; Cold Temperature; Dose-Response Relationship, Drug; Double-Blind Method; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Urticaria; Young Adult

2012
Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
    Acta dermato-venereologica, 2013, Mar-27, Volume: 93, Issue:2

    Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Germany; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Skin; Time Factors; Treatment Outcome; Urticaria; Young Adult

2013
Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
    Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Urticaria

2003
Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin.
    British journal of clinical pharmacology, 2003, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Cetirizine; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Skin; Urticaria

2003
Inhibition of cold urticaria by desloratadine.
    The Journal of dermatological treatment, 2004, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Cold Temperature; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Patient Satisfaction; Urticaria

2004
Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2004, Volume: 92, Issue:6

    Topics: Adolescent; Adult; Anti-Allergic Agents; Area Under Curve; Cetirizine; Cross-Over Studies; Female; Histamine; Humans; Loratadine; Male; Middle Aged; Skin Tests; Time Factors; Urticaria

2004
Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2004, Volume: 34, Issue:9

    Topics: Acetates; Administration, Oral; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Pruritus; Quality of Life; Quinolines; Severity of Illness Index; Sulfides; Treatment Outcome; Urticaria

2004
Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    The Journal of allergy and clinical immunology, 2004, Volume: 114, Issue:3

    Topics: Acetates; Adolescent; Adult; Aged; Chronic Disease; Cyclopropanes; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Quinolines; Sulfides; Treatment Outcome; Urticaria

2004
Safety of desloratadine syrup in children.
    Current medical research and opinion, 2004, Volume: 20, Issue:12

    Topics: Acute Disease; Administration, Oral; Child; Child, Preschool; Double-Blind Method; Electrocardiography; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Placebos; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria

2004
[Desloratadine for chronic idiopathic urticaria].
    Harefuah, 2005, Volume: 144, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Israel; Loratadine; Male; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Urticaria

2005
Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:3

    Topics: Administration, Oral; Adult; Belgium; Chronic Disease; Drug Administration Schedule; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Quality of Life; Severity of Illness Index; Treatment Outcome; Urticaria

2006
Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
    International journal of dermatology, 2006, Volume: 45, Issue:4

    Topics: Adult; Aged; Biomarkers; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Severity of Illness Index; Superoxide Dismutase; Urticaria

2006
A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2006, Volume: 55, Issue:6

    Topics: Adult; Cetirizine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Hypersensitivity, Immediate; Loratadine; Male; Middle Aged; Piperazines; Skin; Skin Tests; Urticaria

2006
Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
    The British journal of dermatology, 2006, Volume: 155, Issue:6

    Topics: Acetates; Administration, Oral; Adolescent; Adult; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Pressure; Quinolines; Skin Tests; Sulfides; Urticaria

2006
Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    American journal of clinical dermatology, 2007, Volume: 8, Issue:1

    Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Pruritus; Severity of Illness Index; Treatment Outcome; Urticaria

2007
[The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2006, Volume: 21, Issue:125

    Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Drug Administration Schedule; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Laser-Doppler Flowmetry; Loratadine; Male; Piperazines; Regional Blood Flow; Skin; Skin Tests; Terfenadine; Treatment Outcome; Urticaria

2006
[Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2006, Volume: 21, Issue:125

    Topics: Administration, Oral; Adult; Cetirizine; Double-Blind Method; Histamine; Histamine H1 Antagonists, Non-Sedating; Humans; Laser-Doppler Flowmetry; Loratadine; Male; Piperazines; Placebos; Skin; Skin Tests; Terfenadine; Treatment Outcome; Urticaria

2006
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:2

    Topics: Adolescent; Adult; Allergens; Cetirizine; Cholinergic Antagonists; Cross-Over Studies; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Piperazines; Prospective Studies; Urticaria

2008
Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Dipyridamole; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Platelet Aggregation Inhibitors; Skin Tests; Treatment Outcome; Urticaria

2008
Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Case-Control Studies; Dapsone; Female; Folic Acid Antagonists; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Prospective Studies; Statistics, Nonparametric; Treatment Outcome; Urticaria

2008
Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:1

    Topics: Activities of Daily Living; Adult; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Sleep; Treatment Outcome; Urticaria

2008
The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Clinical therapeutics, 2000, Volume: 22, Issue:5

    Topics: Anti-Allergic Agents; Biological Availability; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Pharmaceutic Aids; Placebos; Rhinitis, Allergic, Seasonal; Urticaria

2000
Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    International journal of dermatology, 2001, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Cholinergic Antagonists; Chronic Disease; Dizziness; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Loratadine; Male; Middle Aged; Pharyngitis; Pruritus; Respiratory Tract Infections; Treatment Outcome; Urticaria; Virus Diseases

2001

Other Studies

21 other study(ies) available for desloratadine and Hives

ArticleYear
Salt-dependent aquagenic urticaria in children: Report of two cases.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2018, Volume: 29, Issue:3

    Topics: Child; Chronic Inducible Urticaria; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Skin Tests; Sodium Chloride; Urticaria

2018
The treatment outcomes and dose de-escalation of desloratadine up-dosing in chronic spontaneous urticaria.
    International journal of dermatology, 2018, Volume: 57, Issue:4

    Topics: Adult; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Maintenance Chemotherapy; Male; Middle Aged; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Treatment Outcome; Urticaria; Young Adult

2018
[Association of CACNA1C gene genetic polymorphism with the susceptibility as well as prognosis for chronic spontaneous urticaria].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Sep-28, Volume: 43, Issue:9

    Topics: Calcium Channels, L-Type; Chronic Disease; Genetic Predisposition to Disease; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Urticaria

2018
A Patient with Jaundice and Pruritus, Not the Usual Suspect?
    Gastroenterology, 2019, Volume: 157, Issue:1

    Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Glucocorticoids; Glutamyl Aminopeptidase; Hepatitis, Autoimmune; Histamine H1 Antagonists, Non-Sedating; Humans; Hyperbilirubinemia; Jaundice; Loratadine; Male; Prednisolone; Pruritus; Urticaria

2019
Real-life experience in the treatment of solar urticaria: retrospective cohort study.
    Clinical and experimental dermatology, 2019, Volume: 44, Issue:5

    Topics: Acetates; Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cohort Studies; Cyclopropanes; Disease Management; Female; Histamine Antagonists; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Omalizumab; Photosensitivity Disorders; Quinolines; Retrospective Studies; Sulfides; Terfenadine; Urticaria; Young Adult

2019
[Urticaria multiforme is a variation of urticaria, which imitates erythema multiforme].
    Ugeskrift for laeger, 2013, Feb-11, Volume: 175, Issue:7

    Topics: Amoxicillin; Anti-Bacterial Agents; Diagnosis, Differential; Drug Eruptions; Erythema Multiforme; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Loratadine; Male; Pneumonia; Treatment Outcome; Urticaria

2013
Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:5

    Topics: Anti-Allergic Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Middle Aged; Omalizumab; Urticaria

2015
Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
    Journal of dermatological science, 2014, Volume: 76, Issue:3

    Topics: Adolescent; Adult; Aged; Asian People; Benzimidazoles; Case-Control Studies; China; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Anaphylatoxin C5a; Risk Factors; Treatment Outcome; Urticaria; Young Adult

2014
Treatment of solar urticaria using antihistamine and leukotriene receptor antagonist combinations tailored to disease severity.
    Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:6

    Topics: Acetates; Adolescent; Adult; Cetirizine; Child; Child, Preschool; Cyclopropanes; Drug Therapy, Combination; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Leukotriene Antagonists; Loratadine; Male; Middle Aged; Photosensitivity Disorders; Quinolines; Remission Induction; Remission, Spontaneous; Severity of Illness Index; Sulfides; Sunlight; Terfenadine; Ultraviolet Rays; Urticaria; Young Adult

2015
Two Young Children with Rashes on Their Trunk and Extremities.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Diagnosis, Differential; Exanthema; Extremities; Histamine H1 Antagonists, Non-Sedating; Humans; Infant; Loratadine; Torso; Urticaria

2015
Follicular Traction Urticaria: A New Form of Chronic Inducible Urticaria?
    Acta dermato-venereologica, 2017, 04-06, Volume: 97, Issue:4

    Topics: Administration, Oral; Biopsy; Chronic Disease; Drug Administration Schedule; Female; Hair Follicle; Hair Removal; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Physical Stimulation; Risk Factors; Tablets; Terminology as Topic; Treatment Outcome; Urticaria; Young Adult

2017
Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine.
    The Journal of allergy and clinical immunology, 2017, Volume: 139, Issue:4

    Topics: Adult; Chronic Disease; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; ORAI1 Protein; Polymorphism, Single Nucleotide; Urticaria

2017
Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:3

    Topics: Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Sleep; Urticaria; Young Adult

2009
Aquagenic urticaria in 2 adolescents.
    Journal of investigational allergology & clinical immunology, 2010, Volume: 20, Issue:7

    Topics: Adolescent; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Urticaria; Water

2010
Positive basophil activation test result in a patient with acute urticaria induced by cetirizine and desloratadine.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2011, Volume: 106, Issue:3

    Topics: Adult; Basophils; Cetirizine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Urticaria

2011
Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2011, Volume: 110, Issue:3

    Topics: Adolescent; Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Taiwan; Treatment Outcome; Urticaria; Young Adult

2011
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2005, Volume: 54, Issue:9

    Topics: Animals; Cetirizine; CHO Cells; Cricetinae; Cricetulus; Histamine H1 Antagonists; Humans; Loratadine; Piperazines; Predictive Value of Tests; Receptors, Histamine H1; Recombination, Genetic; Terfenadine; Urticaria

2005
Desloratadine: A new, nonsedating, oral antihistamine.
    The Journal of allergy and clinical immunology, 2001, Volume: 107, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Drug Interactions; Histamine H1 Antagonists; Humans; Loratadine; Rhinitis, Allergic, Seasonal; Urticaria

2001
Desloratadine.
    Drugs, 2001, Volume: 61, Issue:6

    Topics: Asthma; Clinical Trials as Topic; Drug Interactions; Histamine H1 Antagonists; Humans; Loratadine; Rhinitis, Allergic, Seasonal; Urticaria

2001
[Urticaria. Finally undisturbed sleep].
    MMW Fortschritte der Medizin, 2001, Jul-26, Volume: 143, Issue:30

    Topics: Clinical Trials as Topic; Double-Blind Method; Histamine H1 Antagonists; Humans; Loratadine; Sleep; Treatment Outcome; Urticaria

2001
Desloratadine (Clarinex).
    The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126

    Topics: Administration, Oral; Adolescent; Adult; Aged; Asthma; Controlled Clinical Trials as Topic; Disorders of Excessive Somnolence; Double-Blind Method; Drug Approval; Drug Interactions; Histamine H1 Antagonists; Humans; Loratadine; Middle Aged; Rhinitis, Allergic, Seasonal; Urticaria

2002